XML 141 R65.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS' EQUITY (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Number of Options outstanding    
Beginning balance 3,079,252  
Granted [1] 32,802  
Exercised (1,220,551)  
Expired and forfeited (123,273)  
Ending balance 1,768,230 3,079,252
Exercisable [1] 1,403,701  
Weighted-Average Exercise Price    
Beginning balance $ 48.82  
Granted [1] 0  
Exercised 23.99  
Expired and forfeited 79.84  
Ending balance 62.9 $ 48.82
Exercisable [1] $ 53.66  
Weighted Average Remaining Contractual life, Outstanding 6 years 14 days 6 years 8 months 15 days
Weighted Average Remaining Contractual life, Exercisable [1] 5 years 8 months 19 days  
Aggregate Intrinsic Value, outstanding $ 305,379 $ 435,699
Aggregate Intrinsic Value, exercisable [1] $ 255,421  
[1] Includes 73,074 performance-based options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, and 22,481 in 2024, as applicable.